Labcorp Launches Test Finder, a Generative AI Tool to Simplify Lab Test Search and Reduce Administrative Burden for Healthcare Providers.
ByAinvest
Wednesday, Jul 30, 2025 7:15 am ET1min read
AMZN--
The tool leverages large language model technology and Amazon Bedrock to provide access to thousands of lab tests across multiple therapeutic areas, including oncology, women's health, neurology, and autoimmune disease. This strategic innovation addresses the time-consuming process of test selection, which currently consumes over three hours daily for physicians [3].
According to an American Medical Association (AMA) survey, 57% of physicians view administrative automation through AI as the greatest opportunity for improving healthcare efficiency. Test Finder is designed to reduce administrative burden, freeing up more time for patient care. The tool's ability to provide relevant test recommendations in plain language could significantly enhance the accuracy and efficiency of clinical decision-making.
Labcorp's introduction of Test Finder represents a strategic technological advancement that could strengthen its competitive positioning in the laboratory services market. The tool's innovative approach to test selection could drive increased test volume and revenue, particularly in high-value testing segments. While specific financial projections are not available, this innovation aligns with the broader trend of efficiency-enhancing technologies in healthcare.
Test Finder is available on Labcorp.com, and its implementation covers key therapeutic areas, simplifying access to essential laboratory tests. This tool has the potential to create meaningful differentiation for Labcorp, setting it apart from competitors like Quest Diagnostics in the competitive laboratory services market.
References:
[1] https://www.labcorp.com/test-menu/search
[2] https://economictimes.indiatimes.com/news/new-updates/miracle-after-15-failed-ivfs-and-19-years-of-tears-how-ai-helped-a-couple-finally-have-a-baby/articleshow/122991748.cms
[3] https://www.stocktitan.net/news/LH/labcorp-introduces-test-finder-a-first-of-its-kind-generative-ai-f13huux6eqs1.html
DGX--
LH--
Labcorp has introduced Test Finder, a first-of-its-kind generative AI tool that simplifies lab test search. Developed in collaboration with Amazon Web Services, Test Finder enables healthcare providers to ask questions or describe conditions in plain language and receive curated test recommendations. The tool is available on Labcorp.com and aims to reduce the time spent on test selection, freeing up more time for patient care.
Labcorp, a leading laboratory services provider, has introduced Test Finder, a pioneering generative AI tool developed in collaboration with Amazon Web Services (AWS). This innovative tool aims to simplify the process of selecting appropriate laboratory tests for healthcare providers. Test Finder allows users to input queries in plain language and receive curated test recommendations, addressing a significant challenge in the healthcare sector.The tool leverages large language model technology and Amazon Bedrock to provide access to thousands of lab tests across multiple therapeutic areas, including oncology, women's health, neurology, and autoimmune disease. This strategic innovation addresses the time-consuming process of test selection, which currently consumes over three hours daily for physicians [3].
According to an American Medical Association (AMA) survey, 57% of physicians view administrative automation through AI as the greatest opportunity for improving healthcare efficiency. Test Finder is designed to reduce administrative burden, freeing up more time for patient care. The tool's ability to provide relevant test recommendations in plain language could significantly enhance the accuracy and efficiency of clinical decision-making.
Labcorp's introduction of Test Finder represents a strategic technological advancement that could strengthen its competitive positioning in the laboratory services market. The tool's innovative approach to test selection could drive increased test volume and revenue, particularly in high-value testing segments. While specific financial projections are not available, this innovation aligns with the broader trend of efficiency-enhancing technologies in healthcare.
Test Finder is available on Labcorp.com, and its implementation covers key therapeutic areas, simplifying access to essential laboratory tests. This tool has the potential to create meaningful differentiation for Labcorp, setting it apart from competitors like Quest Diagnostics in the competitive laboratory services market.
References:
[1] https://www.labcorp.com/test-menu/search
[2] https://economictimes.indiatimes.com/news/new-updates/miracle-after-15-failed-ivfs-and-19-years-of-tears-how-ai-helped-a-couple-finally-have-a-baby/articleshow/122991748.cms
[3] https://www.stocktitan.net/news/LH/labcorp-introduces-test-finder-a-first-of-its-kind-generative-ai-f13huux6eqs1.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet